Chapter 3 82 Study Design/N Population/ Mean age SD/ range) Interventions/Duration Outcome Measures (muscle tone/ function, pain, sexual function, pelvic floor symptoms, QoL, PPE) Results PPSS urinary symptoms Pre-to post-treatment: Markedly improved group (p<.001) Moderately improved group ns NIH-CPSI Total score NIH-CPSI urinary symptoms NIH-CPSI QoL Pre-to post-treatment: Markedly improved group (p<.001) Moderately improved group (p<.01) Markedly improved group (p<.05) Moderately improved group ns Markedly improved group (p<.001) Moderately improved group (p<.05) RCT=Randomized Controlled Trial; PFPT=Pelvic Floor Physiotherapy; PF= pelvic floor; IC/PBS=Interstitial Cystitis/Painful Bladder Syndrome; CP/CPPS=Chronic Prostatitis/Chronic Pelvic Pain Syndrome; MTrP=Myofascial Trigger Point; PPE=patient’s perceived effect; QoL=Quality of Life; SHIM=Sexual Health Inventory for Men; FSFI=Female Sexual Function Index; ICSI=Interstitial Cystitis Symptom Index; ICPI=Interstitial Cystitis Problem Index; NIH/CPSI=National Institute of Healh Chronic Prostatitis Symptom Index; GRA=Global Response Assessment; NEWPERFECT=Performance/Endurance/Repetition/Fast/Elevation/Co-contraction/Timing; NA=not applicable; s-EMG=surface Electromyography; MVC=Maximum Voluntary Contraction; EGS=Electrogalvanic Stimulation; TENS=Transcutaneous Electroneurostimulation; SF-12=12-item Short Form Survey; VAS=Visual Analogue Scale; PVD=Provoked Vulvodynia; AUA=American Urological Association Symptom and Bother Score; PPSS=Pelvic Pain Symptom Scale. Note. ns=non-significant Table 2. Continued
RkJQdWJsaXNoZXIy MTk4NDMw